Patient perspectives on fluticasone–vilanterol versus other corticosteroid combination products for the treatment of asthma

OBJECTIVE: Fluticasone furoate (FF), an inhaled corticosteroid (ICS), and vilanterol (VI), a long-acting beta(2) receptor agonist (LABA), is a new combination used in an Ellipta(®) device. This article compares FF–VI to other ICS–LABA combinations available, particularly emphasizing product selectio...

Descripción completa

Detalles Bibliográficos
Autores principales: Bollmeier, Suzanne G, Prosser, Theresa R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874727/
https://www.ncbi.nlm.nih.gov/pubmed/27257375
http://dx.doi.org/10.2147/PPA.S83946